Mastoiditis medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 6: Line 6:


==Overview==
==Overview==
Medical treatment for acute and subacute mastoiditis without intracranial complications is intravenous antibiotics and myringotomy. With only antimicrobial therapy there is a possibility of progression of mastoiditis to further complications. In a study of 223 patients with mastoiditis, 8.5 percent developed complications during antimicrobial therapy.
Medical treatment for acute and subacute mastoiditis without intracranial complications is intravenous [[antibiotics]] and [[myringotomy]]. With only antimicrobial therapy there is a possibility of progression of mastoiditis to further complications. In a study of 223 patients with mastoiditis, 8.5 percent developed complications during antimicrobial therapy. [[Antibiotics]] for acute mastoiditis must cover the most common bacterial pathogens: [[Streptococcus pneumoniae]], [[Streptococcus pyogenes]], and [[Staphylococcus aureus]] (including [[Methicillin-resistant staphylococcus aureus|methicillin-resistant ''S.'' aureus]]). If there is a history of recurrent [[acute otitis media]] or recent antibiotic usage the intravenous antibiotic also should cover the [[Pseudomonas aeruginosa]]. Bacteria commonly should cover are [[Streptococcus pneumonia]], [[Group A streptococcus]], [[Staphylococcus aureus]]. The empiric antibiotics are: [[Ampicillin-Sulbactam|Ampicillin-sulbactam]] or [[ampicillin]]; add [[Vancomycin]] for severe infection with adjacent complications, or suspicion of [[MRSA]]. For chronic mastoiditis bacteria commonly should cover [[Pseudomonas aeruginosa]], [[Staphylococcus aureus]] and [[anaerobes]]. Antibiotics are [[Piperacillin-tazobactam]] or [[Piperacillin]], and [[Ofloxacin]] Otic Solution; add [[Vancomycin]] for severe infection with adjacent complications, or suspicion of [[MRSA]]. Antibiotic selection and dosing may be modified after obtaining the results of culture and antibiotic sensitivity. Serial examination of the postauricular region, the [[tympanic membrane]]; monitoring for [[fever]], [[otalgia]], postauricular tenderness, erythema, swelling, fluctuance, or mass, and narrowing the external auditory canal, is necessary.
Antibiotics for acute mastoiditis must cover the most common bacterial pathogens: Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus (including methicillin-resistant ''S.'' aureus). If there is a history of recurrent acute otitis media or recent antibiotic usage the intravenous antibiotic also should cover the Pseudomonas aeruginosa.Bacteria commonly should cover are Streptococcus pneumonia Group A streptococcus ''Staphylococcus aureus''; and empiric antibiotics are: Ampicillin-sulbactam, ampicillin; ADD Vancomycin for severe infection with adjacent complications, or suspicion of MRSA.
For chronic mastoiditis bacteria commonly should cover Pseudomonas aeruginosa, Staphylococcus aureus and Anaerobes. Antibiotics are Piperacillin-tazobactam, Piperacillin, AND Ofloxacin Otic Solution, add Vancomycin for severe infection with adjacent complications, or suspicion of MRSA. Antibiotic selection and dosing may be modified after obtaining the results of culture and antibiotic sensitivity.
Serial examination of the postauricular region, and the tympanic membrane, fever, otalgia, postauricular tenderness, erythema, swelling, fluctuance, or mass. Narrowing the external auditory canal


==Medical Therapy==
==Medical Therapy==
Line 18: Line 15:


Depends on the patient condition, antibiotic choices may be differs as follows:
Depends on the patient condition, antibiotic choices may be differs as follows:
* Acute mastoiditis (<1 month duration), immunocompetent patient
 
==== Acute mastoiditis (<1 month duration), immunocompetent patient ====
** Bacteria commonly should cover:
** Bacteria commonly should cover:
*** Streptococcus pneumoniae
*** Streptococcus pneumoniae
Line 28: Line 26:
*** ADD Vancomycin 15mg/kg/dose IV q6-8h (initial max 1g/dose) for severe infection with adjacent complications, or suspicion of MRSA
*** ADD Vancomycin 15mg/kg/dose IV q6-8h (initial max 1g/dose) for severe infection with adjacent complications, or suspicion of MRSA


* chronic mastoiditis (>= 1 month duration, usually non-intact tympanic membrane), immunocompetent patient
==== chronic mastoiditis (>= 1 month duration, usually non-intact tympanic membrane), immunocompetent patient ====
** Bacteria commonly should cover:
** Bacteria commonly should cover:
*** Pseudomonas aeruginosa
*** Pseudomonas aeruginosa
Line 44: Line 42:
=== Mastoiditis treatment follow up ===
=== Mastoiditis treatment follow up ===
Treatment response should be monitor via below items, searching for improvement:
Treatment response should be monitor via below items, searching for improvement:
* Serial examination of the postauricular region, and the tympanic membrane, fever, otalgia, postauricular tenderness, erythema, swelling, fluctuance, or mass. Narrowing the external auditory canal
* Serial examination of the postauricular region, the [[tympanic membrane]]; monitoring for [[fever]], [[otalgia]], postauricular tenderness, erythema, swelling, fluctuance, or mass, and narrowing the external auditory canal, is necessary.


==References==
==References==

Revision as of 18:18, 30 June 2017


Mastoiditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mastoiditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]

Overview

Medical treatment for acute and subacute mastoiditis without intracranial complications is intravenous antibiotics and myringotomy. With only antimicrobial therapy there is a possibility of progression of mastoiditis to further complications. In a study of 223 patients with mastoiditis, 8.5 percent developed complications during antimicrobial therapy. Antibiotics for acute mastoiditis must cover the most common bacterial pathogens: Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus (including methicillin-resistant S. aureus). If there is a history of recurrent acute otitis media or recent antibiotic usage the intravenous antibiotic also should cover the Pseudomonas aeruginosa. Bacteria commonly should cover are Streptococcus pneumonia, Group A streptococcus, Staphylococcus aureus. The empiric antibiotics are: Ampicillin-sulbactam or ampicillin; add Vancomycin for severe infection with adjacent complications, or suspicion of MRSA. For chronic mastoiditis bacteria commonly should cover Pseudomonas aeruginosa, Staphylococcus aureus and anaerobes. Antibiotics are Piperacillin-tazobactam or Piperacillin, and Ofloxacin Otic Solution; add Vancomycin for severe infection with adjacent complications, or suspicion of MRSA. Antibiotic selection and dosing may be modified after obtaining the results of culture and antibiotic sensitivity. Serial examination of the postauricular region, the tympanic membrane; monitoring for fever, otalgia, postauricular tenderness, erythema, swelling, fluctuance, or mass, and narrowing the external auditory canal, is necessary.

Medical Therapy

Medical treatment for acute and subacute mastoiditis without intracranial complications is intravenous antibiotics and myringotomy. With only antimicrobial therapy there is a possibility of progression of mastoiditis to further complications. In a study of 223 patients with mastoiditis, 8.5 percent developed complications during antimicrobial therapy [1][2]

Empiric antibiotic therapy

Antibiotics for acute mastoiditis must cover the most common bacterial pathogens: Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus (including methicillin-resistant S. aureus). If there is a history of recurrent acute otitis media or recent antibiotic usage the intravenous antibiotic also should cover the Pseudomonas aeruginosa.

Depends on the patient condition, antibiotic choices may be differs as follows:

Acute mastoiditis (<1 month duration), immunocompetent patient

    • Bacteria commonly should cover:
      • Streptococcus pneumoniae
      • Group A streptococcus
      • Staphylococcus aureus
    • Antibiotics:
      • Ampicillin-sulbactam 50mg/kg/dose
      • ampicillin IV q6h (max 2g ampicillin/dose)
      • ADD Vancomycin 15mg/kg/dose IV q6-8h (initial max 1g/dose) for severe infection with adjacent complications, or suspicion of MRSA

chronic mastoiditis (>= 1 month duration, usually non-intact tympanic membrane), immunocompetent patient

    • Bacteria commonly should cover:
      • Pseudomonas aeruginosa
      • Staphylococcus aureus
      • Anaerobes
    • Antibiotics
      • Piperacillin-tazobactam (Zosyn) 100mg/kg/dose
      • Piperacillin IV q6h (max 4g piperacillin/dose)
      • AND Ofloxacin Otic Solution 10 drops to affected ear BID
      • ADD Vancomycin 15mg/kg/dose IV q6-8h (initial max 1g/dose) for severe infection with adjacent complications, or suspicion of MRSA

Antibiotic selection and dosing may be modified after obtaining the results of culture and antibiotic sensitivity.

Mastoiditis treatment follow up

Treatment response should be monitor via below items, searching for improvement:

  • Serial examination of the postauricular region, the tympanic membrane; monitoring for fever, otalgia, postauricular tenderness, erythema, swelling, fluctuance, or mass, and narrowing the external auditory canal, is necessary.

References

  1. Luntz M, Brodsky A, Nusem S, Kronenberg J, Keren G, Migirov L, Cohen D, Zohar S, Shapira A, Ophir D, Fishman G, Rosen G, Kisilevsky V, Magamse I, Zaaroura S, Joachims HZ, Goldenberg D (2001). "Acute mastoiditis--the antibiotic era: a multicenter study". Int. J. Pediatr. Otorhinolaryngol. 57 (1): 1–9. PMID 11165635.
  2. "Pediatric Guidelines: Head and Neck Infections - Mastoiditis | Infectious Diseases Management Program at UCSF".

Template:WH Template:WS